
Investments
277Funds
6Service Providers
1About RA Capital Management
RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. The firm provides seed funding to startups and leads private, IPO, and follow-on financings for its portfolio companies, thereby driving value creation from idea inception through commercialization.
RA Capital Management Headquarter Location
200 Berkeley Street 18th Floor
Boston, Massachusetts, 02116,
United States
Expert Collections containing RA Capital Management
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find RA Capital Management in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
RA Capital Management Web Traffic
RA Capital Management Rank
Research containing RA Capital Management
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned RA Capital Management in 3 CB Insights research briefs, most recently on Aug 5, 2021.
Aug 5, 2021
Here Are The Most Active Healthcare InvestorsMay 20, 2020
Here Are Q1’s Most Active Healthcare InvestorsLatest RA Capital Management News
Jun 22, 2022
Wave Life Sciences (NASDAQ: WVE ) has disclosed a share purchase by 10% owner Ra Capital Management. Ra Capital Management bought over 9.48M shares of the company's ordinary shares at $2.15 in a transaction dated June 16, 2022. It now becomes the beneficial owner of 17,202,009 shares of the issuer's ordinary shares which constitute ~19.99% of the class outstanding. The fund also holds pre-funded warrants through which it has a right to acquire 7,093,656 ordinary shares. The pre-funded warrants contain a provision which precludes exercise of the warrants to the extent that, following exercise, the fund, together with its affiliates and other attribution parties, would own more that 19.99% of the ordinary shares outstanding. The additional securities were acquired for an aggregate of $35.63M. The purchases were for cash and were funded by the working capital of the fund. WVE shares up over 8% pre-market To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
RA Capital Management Investments
277 Investments
RA Capital Management has made 277 investments. Their latest investment was in Cerebral Therapeutics as part of their Series C on June 6, 2022.
RA Capital Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/28/2022 | Series C | Cerebral Therapeutics | $40M | No | 3 | |
6/8/2022 | Series B | Mineralys Therapeutics | $118M | Yes | 6 | |
4/19/2022 | Series B | Sionna Therapeutics | $111M | Yes | 4 | |
4/14/2022 | Series B | |||||
4/13/2022 | Series A |
Date | 6/28/2022 | 6/8/2022 | 4/19/2022 | 4/14/2022 | 4/13/2022 |
---|---|---|---|---|---|
Round | Series C | Series B | Series B | Series B | Series A |
Company | Cerebral Therapeutics | Mineralys Therapeutics | Sionna Therapeutics | ||
Amount | $40M | $118M | $111M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 3 | 6 | 4 |
RA Capital Management Fund History
6 Fund Histories
RA Capital Management has 6 funds, including RA Capital Nexus Fund III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
10/6/2021 | RA Capital Nexus Fund III | $880M | 1 | ||
10/21/2020 | RA Capital Nexus Fund II | ||||
7/15/2019 | RA Capital Nexus Fund | ||||
7/12/2019 | RA Capital Nexus International Fund | ||||
RA Capital Healthcare Fund LP |
Closing Date | 10/6/2021 | 10/21/2020 | 7/15/2019 | 7/12/2019 | |
---|---|---|---|---|---|
Fund | RA Capital Nexus Fund III | RA Capital Nexus Fund II | RA Capital Nexus Fund | RA Capital Nexus International Fund | RA Capital Healthcare Fund LP |
Fund Type | |||||
Status | |||||
Amount | $880M | ||||
Sources | 1 |
RA Capital Management Service Providers
1 Service Provider
RA Capital Management has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type |
Partnership data by VentureSource
RA Capital Management Team
9 Team Members
RA Capital Management has 9 team members, including current Founder, Managing Partner, Peter Kolchinsky.
Name | Work History | Title | Status |
---|---|---|---|
Peter Kolchinsky | Founder, Managing Partner | Current | |
Michael Saulnier | Baupost Group, Centerbridge Partners, Citigroup, Ernst & Young, and Morgan Stanley | Chief Financial Officer | Current |
Chris Caliri | Bain Capital, and SunGard | Chief Information Officer | Current |
Klio DiCenzo | athenahealth, PwC, MetLife, and Bank of America | Chief People Officer | Current |
Eric Rose | Chief Compliance Officer | Current |
Name | Peter Kolchinsky | Michael Saulnier | Chris Caliri | Klio DiCenzo | Eric Rose |
---|---|---|---|---|---|
Work History | Baupost Group, Centerbridge Partners, Citigroup, Ernst & Young, and Morgan Stanley | Bain Capital, and SunGard | athenahealth, PwC, MetLife, and Bank of America | ||
Title | Founder, Managing Partner | Chief Financial Officer | Chief Information Officer | Chief People Officer | Chief Compliance Officer |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.